chevron_leftBack
As of 24 April 2025, Imeik Technology Development Co.,Ltd. has a market cap of $7.21B USD, ranking #2180 globally and #297 in China. It ranks #191 in the Healthcare sector, and #21 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$7.21BUSD
52.57B CNY
Enterprise Value
$6.59BUSD
48.03B CNY
Revenue (TTM)
$415.21MUSD
3.03B CNY
EBITDA (TTM)
$298.06MUSD
2.17B CNY
Net Income (TTM)
$268.64MUSD
1.96B CNY
EBITDA Margin
72%
Profit Margin
65%
PE Ratio
26.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Yifeng Shi
open_in_new
Employees
1,223
Founded
2004
Website
imeik.net/cn/
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.6% | -5.1% | -8.4% | 1.7% | -21% | -14% |
Upcoming Earnings
Earnings Date
Fri, Apr 25
Tomorrow
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300896
爱美客技术发展股份有限公司 Class A
ISIN: CNE100004868
Shares Out.:
Shares Outstanding:
301.426M1
Shares Float:
174.572M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
174.40 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Imeik Technology Development Co.,Ltd.
Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel. It also provides skin care products. Imeik Technology Development Co.,Ltd. was incorporated in 2004 and is based in Beijing, China.
